EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems

Peter G Jacobs iD, Carol J Levy iD, Sue A Brown, Michael C Riddell iD, Ali Cinar iD, Charlotte K Boughton iD, Marc D Breton iD, Eyal Dassau iD, Greg Forlenza iD, Robert J Henderson, Roman Hovorka, David M Maahs und 9 weitere

Diabetes Technology & Therapeutics · 2025

DOI: 10.1089/dia.2025.0129 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes Technology & Therapeutics, 2025. Verfasst von Peter G Jacobs und 20 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioengineering, Oregon State University, Corvallis, Oregon, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Insulin, Hypoglycemic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the discovery of the life-saving hormone insulin in 1921 by Dr. Frederick Banting in 1921, there have been many critical discoveries and technical breakthroughs that have enabled people living with type 1 diabetes (T1D) to live longer, healthier lives. The development of insulin pumps, continuous glucose monitoring systems, and automated insulin delivery (AID) systems has enabled people living with T1D to safely manage their glucose, reduce their HbA1c, and improve their overall health and quality of life. Nevertheless, AID systems are not yet designed for all people with T1D, and they perform best during the overnight period when meals and exercise are not occurring. AID systems are not fully automated in that they require the person using the system to announce meals and exercise to the system to avoid dangerous hyper- or hypoglycemia, respectively. In this review, which is one of a collection of articles to commemorate the 75th anniversary of the National Institute for Diabetes and Digestive and Kidney Diseases, we celebrate the commercialization of the AID and discuss the major challenges and research gaps that remain to be solved to enable single- and multihormone AID systems to more fully support glucose management in people living with T1D. More research is required to design and evaluate more intelligent AID systems that do not require accurate carbohydrate estimations or announcements for meals and exercise. Current AID systems are also not designed to be used by older adults or pregnant people. Results are presented on new AID systems that can automatically respond to meals and exercise. Results are also presented on evaluations of AID systems in older adults and pregnant people. Next-generation AID systems will need to support all people, including older adults, people during pregnancy, athletes, and people who may be too busy to announce carbohydrates or exercise to the system. Solutions are now becoming available that will enable AID systems to support a broader range of people living with T1D by leveraging the latest technologies in artificial intelligence and adaptive control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Insulin Infusion SystemsInsulinHypoglycemic AgentsHumansBlood Glucose Self-MonitoringBlood GlucosePancreas, ArtificialPregnancyFemaleEvidence Gaps

Stichwörter der Autor:innen

CGMCSIIHbA1cartificial pancreasautomated insulin deliveryexercisehyperglycemiahypoglycemiainsulin pumpolder adultsphysical activitypregnancytime below rangetime in range

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • College of Bioengineering, Oregon State University, Corvallis, Oregon, USA.
  • Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, USA.
  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • University of Virginia, Charlottesville, Virginia, USA.
  • York University, Toronto, Canada.
  • Department of Chemical and Biological Engineering, Illinois Institute of Technology, Chicago, Illinois, USA.

ORCID-Profile: Peter G Jacobs, Carol J Levy, Michael C Riddell, Ali Cinar, Charlotte K Boughton, Marc D Breton, Eyal Dassau, Greg Forlenza, Medha Munshi, Sarit Polsky, Viral N Shah, Leah M Wilson, Laya Ekhlaspour

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Jacobs, P. G., Levy, C. J., Brown, S. A., Riddell, M. C., Cinar, A., Boughton, C. K., Breton, M. D., Dassau, E., Forlenza, G., Henderson, R. J., Hovorka, R., Maahs, D. M., Munshi, M., Murphy, H., Polsky, S., Pratley, R., Putman, M. S., Shah, V. N., Wilson, L. M., …, & Ekhlaspour, L. (2025). Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2025.0129

Vancouver

Jacobs PG, Levy CJ, Brown SA, Riddell MC, Cinar A, Boughton CK, et al. Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems. Diabetes Technology & Therapeutics. 2025. doi:10.1089/dia.2025.0129

BibTeX
@article{Jacobs2025,
  author = {Jacobs, Peter G and Levy, Carol J and Brown, Sue A and Riddell, Michael C and Cinar, Ali and Boughton, Charlotte K and Breton, Marc D and Dassau, Eyal and Forlenza, Greg and Henderson, Robert J and Hovorka, Roman and Maahs, David M and Munshi, Medha and Murphy, Helen and Polsky, Sarit and Pratley, Richard and Putman, Melissa S and Shah, Viral N and Wilson, Leah M and Zisser, Howard and Ekhlaspour, Laya},
  title = {Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems},
  journal = {Diabetes Technology & Therapeutics},
  year = {2025},
  doi = {10.1089/dia.2025.0129}
}
Kostenlos starten →